
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 1051 | 1177 | 1293 | 1538 | 1825 |
Fund Return | 6.34% | 5.09% | 17.68% | 8.96% | 9% | 6.2% |
Place in category | 275 | 308 | 228 | 156 | 126 | 86 |
% in Category | 52 | 55 | 43 | 30 | 30 | 27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Fund | 5.17B | 6.31 | 9.09 | 6.25 | ||
Royal London European Growth Fund C | 2.5B | 9.80 | 9.59 | 8.15 | ||
Royal London US Tracker Z Fund Accu | 1.33B | -1.33 | 14.21 | 14.47 | ||
Royal London UK Equity Income A | 1.17B | 5.12 | 8.81 | 5.78 | ||
Royal London UK Equity Income Fund | 1.17B | 5.19 | 9.30 | 6.39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.8B | 6.89 | 8.27 | 6.15 | ||
VG UK Plus GBP Accumulation | 14.8B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 14.8B | 9.34 | 5.75 | 6.11 | ||
All Share Index Unit Trust Income | 14.8B | 9.33 | 5.75 | 6.09 | ||
UK Equity Tracker Fund D Acc | 12.27B | 6.05 | 8.74 | 6.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.64 | 11,480.0 | -3.06% | |
Shell | GB00BP6MXD84 | 6.30 | 30.51 | -0.97% | |
HSBC | GB0005405286 | 6.03 | 841.60 | -1.54% | |
ICF FTSE 100 IDX FUT MAR25 | GB00KNSR9V84 | 4.58 | - | - | |
Unilever | GB00B10RZP78 | 4.49 | 54.34 | -3.03% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review